CD95 AND BCL-2 EXPRESSION AS APOPTOTIC MARKERS IN RHEUMATOID PATIENTS

被引：0
|
作者：
Ahmad, M. Sayed [1 ]
Elsawy, N. [1 ]
Imam, M. [1 ]
Gad, M. [1 ]
Alzawawy, A. [1 ]
机构：
[1] Univ Alexandria, Alexandria, Egypt
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2011年 / 29卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
213
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [21] EXPRESSION OF CD95 AND BCL-2 PROTEINS IN LOW-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    NGUYEN, PL
    ROBERTSON, MJ
    RITZ, J
    HARRIS, NL
    LABORATORY INVESTIGATION, 1995, 72 (01) : A118 - A118
  • [22] CD95 and CD95 ligand expression in very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    MacKie, RM
    Gore, ME
    Bunker, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 554 - 554
  • [23] Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics
    C Wuchter
    L Karawajew
    V Ruppert
    T Büchner
    C Schoch
    T Haferlach
    R Ratei
    B Dörken
    W-D Ludwig
    Leukemia, 1999, 13 : 1943 - 1953
  • [24] Differential expression of Bcl-2, Bax, and CD95 in DNA repair-proficient and DNA repair-deficient basal cell carcinoma patients
    Abid, K.
    Fazaa, B.
    Hadouchi, Ch.
    El Mezni, F.
    Kamoun, M. R.
    Hamzaoui, K.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (12) : 1482 - 1485
  • [25] Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia
    Wuchter, C
    Karawajew, L
    Ruppert, V
    Schrappe, M
    Harbott, J
    Ratei, R
    Dörken, B
    Ludwig, WD
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 154 - 160
  • [26] Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics
    Wuchter, C
    Karawajew, L
    Ruppert, V
    Büchner, T
    Schoch, C
    Hafelach, T
    Ratei, R
    Dörken, B
    Ludwig, WD
    LEUKEMIA, 1999, 13 (12) : 1943 - 1953
  • [27] APO-1 (CD95) AND BCL-2 - DETERMINANTS OF CELL-DEATH IN THE HUMAN THYMUS
    DEBATIN, KM
    RESEARCH IN IMMUNOLOGY, 1994, 145 (02): : 146 - 151
  • [28] Expression of bcl-2 in rheumatoid arthritis
    Isomaki, P
    Soderstrom, KO
    Punnonen, J
    Roivainen, A
    Luukkainen, R
    MerilahtiPalo, R
    Nikkari, S
    Lassila, O
    Toivanen, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (07): : 611 - 619
  • [29] Expression of CD 95, Bax and Bcl-2 in conventional highly malignant osteosarcoma
    Radig, K
    Haeckel, C
    Halm-Heinrich, I
    Mittler, U
    Roessner, A
    PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 362 - 366
  • [30] The apoptotic members CD95, BclxL, and Bcl-2 cooperate to promote cell migration by inducing Ca2+ flux from the endoplasmic reticulum to mitochondria
    Fouque, A.
    Lepvrier, E.
    Debure, L.
    Gouriou, Y.
    Malleter, M.
    Delcroix, V.
    Ovize, M.
    Ducret, T.
    Li, C.
    Hammadi, M.
    Vacher, P.
    Legembre, P.
    CELL DEATH AND DIFFERENTIATION, 2016, 23 (10): : 1702 - 1716
12345